Envigo
Envigo provides the broadest range of research models and related services to the pharmaceutical and biotechnology industries, government, academia, and other life science organizations. As the largest organization that is solely dedicated to providing research models and related products and services, we are committed to helping researchers realize the full potential of their critical R&D projects as we fulfill our mission to work together to build a healthier and safer world. Read more at envigo.com
Website
Headquarters
Indianapolis, IN, United States; facilities in 14+ countries
Company Size
1,200
-
OCT 19, 2022 | 10:00 AM
Date: October 19, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) In this webinar, we will introduce the generation and applications of Biocytogen’s severely immunodeficient (B-N... -
OCT 05, 2022 | 11:00 AM
Date: October 05, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) The effects of fiber in health and disease is an active subject of research in a range of research areas. Historically...
-
APR 27, 2022 | 8:00 AM
Date: April 27, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Join Mick D. Edmonds, PhD, Assistant Professor and Director, Genetic and Genomic Sciences Program at University of Alabam...
-
DEC 07, 2021 | 9:00 AM
Date: December 7, 2021 Time: 9:00am (PST), 12:00pm (EST) The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than...
-
OCT 07, 2021 | 10:00 AM
Date: October 07, 2021 Time: 10:00am (PDT), 1:00pm (EDT) It's estimated than less than 10% of investigational anti-cancer drugs successfully achieve FDA approval for clinical use. This i...
-
OCT 11, 2017 | 10:30 AM
The “R2G2” (B6;129-Rag2tm1FwaIL2rgtm1Rsky/DwlHsd) knockout mouse is the latest advancement to provide an alternative option in the highly immunodeficient mouse model category for...
